US Stock MarketDetailed Quotes

SLS Sellas Life Sciences

Watchlist
  • 1.320
  • +0.050+3.94%
Close Feb 14 16:00 ET
  • 1.320
  • -0.001-0.04%
Post 19:56 ET
103.73MMarket Cap-1.97P/E (TTM)

About Sellas Life Sciences Company

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

Company Profile

SymbolSLS
Company NameSellas Life Sciences
Listing DateMar 12, 2008
Founded2006
CEODr. Angelos M. Stergiou, M.D.
MarketNASDAQ
Employees16
Fiscal Year Ends12-31
AddressTimes Square Tower,7 Times Square,Suite 2503
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10026
Phone1-646-200-5278
Websitehttp://www.sellaslifesciences.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Angelos M. Stergiou, M.D.
  • Director, President and Chief Executive Officer
  • 1.75M
  • Dr. Dragan Cicic, M.D.
  • Senior Vice President and Chief Development Officer
  • --
  • John T. Burns, C.P.A.
  • Senior Vice President, Finance, Chief Financial Officer and Chief Accounting Officer
  • 783.11K
  • Jane Wasman, J.D.
  • Chairman of the Board
  • 136.28K
  • Robert L. Van Nostrand
  • Independent Director
  • 106.28K
  • John Varian
  • Independent Director
  • 110.50K
  • Katherine Bach Kalin, M.B.A.
  • Independent Director
  • 92.50K
  • Dr. David A. Scheinberg,M.D.,PhD
  • Independent Director
  • 102.50K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Hengerda New Materials
300946
+20.01%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
4
Cubic Digital Technology
300344
+19.98%
5
HNAC Technology
300490
+19.95%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!